What to Expect: Your First Allara Medical Visit

What Allara Health Actually Treats

Allara Health is a telehealth practice built around hormonal and metabolic conditions in people with ovaries. The platform is not a general-practice substitute. Its clinical scope covers PCOS, thyroid dysfunction, insulin resistance, adrenal conditions, and related concerns like hirsutism, irregular cycles, and fertility optimization.

PCOS as the Core Clinical Focus

PCOS affects an estimated 6 to 12 percent of reproductive-age women in the United States, making it one of the most common endocrine disorders in this population, according to CDC prevalence data (CDC, Reproductive Health). Despite how common it is, diagnosis is frequently delayed by four to five years from symptom onset, according to a 2017 survey published in the Journal of Clinical Endocrinology and Metabolism (Banting et al., JCEM). Allara's intake process is designed to catch that gap.

The Rotterdam Criteria remain the standard diagnostic framework for PCOS. A diagnosis requires two of the following three features: oligo-ovulation or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound (Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Human Reproduction, 2004). Your Allara provider will map your history against these criteria during the first visit.

Other Conditions Allara Addresses

Thyroid disorders frequently co-occur with PCOS. A 2018 meta-analysis in Frontiers in Endocrinology found that women with PCOS had a significantly higher prevalence of Hashimoto's thyroiditis compared to controls (odds ratio 3.27, 95% CI 2.42 to 4.42) (Sinha et al., 2018). Allara's lab panels typically include thyroid-stimulating hormone (TSH) and free T4 for this reason.

Insulin resistance is present in 65 to 70 percent of women with PCOS regardless of BMI, according to research published in Diabetes Care (Stepto et al., 2013). Identifying it early changes both lifestyle and medication recommendations, particularly around metformin initiation.

Before the Visit: Intake, Insurance, and Preparation

Most of what determines the quality of your first visit happens before the camera turns on. Allara sends a detailed intake questionnaire after you book. Completing it thoroughly takes 20 to 40 minutes and covers menstrual history, symptoms, past diagnoses, medications, family history, and lifestyle factors.

What to Gather Before You Log In

Bring the following to your appointment. Having these ready prevents the visit from becoming an administrative session instead of a clinical one.

• A list of current medications, including over-the-counter supplements and doses
• Any prior hormone lab results (testosterone, DHEAS, LH, FSH, estradiol, insulin, HbA1c)
• A menstrual cycle log going back at least three months, including cycle length and flow characteristics
• Records of any prior ultrasound reports mentioning ovarian morphology
• Your insurance card and member ID

Lab Work: Before or After?

Allara's standard practice is to order a baseline hormone and metabolic panel at or shortly after the first visit. If you have recent labs (within 90 days), your provider will review those instead of duplicating bloodwork. The standard first panel typically includes total and free testosterone, DHEAS, LH, FSH, estradiol (day-three draw if possible), fasting insulin, fasting glucose, HbA1c, TSH, free T4, and a complete metabolic panel.

The American Association of Clinical Endocrinology (AACE) recommends fasting prior to a morning blood draw for the most accurate androgen and insulin measurements (AACE Clinical Practice Guidelines).

The Appointment Itself: A Minute-by-Minute Breakdown

The first Allara visit follows a consistent structure, though providers adapt based on symptom complexity. Knowing what to expect helps you use the time well.

Opening: History Review (0 to 10 Minutes)

Your provider will confirm the chief complaint and verify the intake information you submitted. They will ask clarifying questions about symptom onset, severity, and what has or has not worked before. This portion is conversational, not interrogative. Expect questions like: "When did your cycles first become irregular?" and "Has anyone in your family been diagnosed with diabetes or thyroid disease?"

Middle: Physical Symptom Assessment (10 to 30 Minutes)

Because Allara is telehealth, the physical exam is limited. Providers use a structured visual and verbal assessment. They may ask you to show areas of excess hair growth (hirsutism), acne distribution, or skin changes like acanthosis nigricans, which appears as darkened, velvety skin at the neck or underarms and signals insulin resistance.

The Ferriman-Gallwey score is the standard clinical tool for quantifying hirsutism. A score of 8 or above in most ethnic groups indicates clinically significant androgen excess (Yildiz et al., Human Reproduction, 2010). Providers can guide this assessment verbally during the video call.

End: Diagnosis, Planning, and Questions (30 to 60 Minutes)

The last portion of the visit is where your provider presents their working assessment. If the Rotterdam Criteria are met by history alone, they may give a provisional PCOS diagnosis and start treatment before labs return. If the picture is ambiguous, they will classify your presentation as "possible PCOS pending labs" and schedule a follow-up to confirm.

A written care plan, usually delivered through the patient portal within 24 to 48 hours, will outline the diagnosis, recommended medications or supplements, lifestyle targets, and the follow-up schedule.

What Medications Are Commonly Prescribed at the First Visit

Not everyone leaves the first visit with a prescription. Whether a provider starts medication immediately depends on symptom severity, diagnostic clarity, and whether labs have returned. The following are the most common first-line agents discussed or prescribed.

Metformin

Metformin (extended-release, typically 500 to 1,500 mg daily) is used off-label for PCOS to improve insulin sensitivity and reduce androgen levels. A 2012 Cochrane review found that metformin improved menstrual frequency and reduced androgen concentrations in women with PCOS compared to placebo, though the effect on live birth rate was less consistent when compared to clomiphene (Costello et al., Cochrane Database, 2012). The American College of Obstetricians and Gynecologists (ACOG) notes that metformin is reasonable for metabolic management in PCOS even in patients without frank diabetes (ACOG Practice Bulletin 194).

Spironolactone

Spironolactone (25 to 200 mg daily) is an aldosterone antagonist used off-label for androgen-driven symptoms like hirsutism and acne. It blocks androgen receptors in the skin. Clinical improvement in hirsutism typically appears after three to six months of consistent use. Providers almost always require reliable contraception before starting spironolactone due to teratogenic risk in male fetuses.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) reduce ovarian androgen production and regulate the menstrual cycle. The Endocrine Society's 2023 clinical practice guideline on PCOS lists COCs as a first-line pharmacological treatment for menstrual irregularity and hyperandrogenism in patients not seeking pregnancy (Endocrine Society Clinical Practice Guideline, 2023).

Inositol Supplementation

Myo-inositol and D-chiro-inositol are not FDA-approved drugs but are frequently recommended as adjuncts. A 2016 meta-analysis in Gynecological Endocrinology found that myo-inositol supplementation improved insulin sensitivity and reduced testosterone in women with PCOS compared to placebo (Unfer et al., 2016). The standard evidence-based ratio is 40:1 myo-inositol to D-chiro-inositol.

Lab Results and the Follow-Up Visit

Labs take three to seven business days at most commercial labs. Your Allara provider reviews results and messages you through the portal with an interpretation. If anything falls outside reference range or changes the clinical picture, they will either send a message with adjusted recommendations or schedule a follow-up sooner than the standard four to eight weeks.

Reading Your Own Hormone Panel

Knowing what the numbers mean helps you have a better follow-up conversation. Below are the reference ranges most commonly flagged in PCOS workups.

| Marker | Standard Reference Range | PCOS-Associated Pattern | |---|---|---| | Total testosterone | 15 to 70 ng/dL | Elevated (>70 ng/dL) | | Free testosterone | 0.6 to 6.8 pg/mL | Elevated | | DHEAS | 35 to 430 mcg/dL | Often elevated | | LH:FSH ratio | Approximately 1:1 | Often >2:1 in PCOS | | Fasting insulin | <25 mIU/L | >25 suggests IR | | HbA1c | <5.7% | >5.7% suggests prediabetes |

Reference ranges sourced from the National Institutes of Health MedlinePlus laboratory reference tables (NIH MedlinePlus).

When to Escalate Before Your Follow-Up

Contact Allara through the patient portal before your scheduled follow-up if you experience any of the following: new or worsening pelvic pain, a missed period after starting an oral contraceptive, side effects from metformin that do not resolve within two weeks (severe nausea, persistent diarrhea), or any new symptom you think may be medication-related.

Lifestyle Recommendations You Will Likely Receive

Medication is rarely the whole plan. Every Allara care plan includes lifestyle targets. The evidence base for lifestyle intervention in PCOS is clear: a 5 to 10 percent reduction in body weight in women with PCOS who have overweight or obesity significantly improves menstrual regularity and reduces androgen levels, according to a systematic review in Human Reproduction Update (Lim et al., 2019).

Nutrition Guidance

Allara providers typically recommend a lower-glycemic eating pattern rather than a specific named diet. The goal is reducing postprandial insulin spikes. A 2020 randomized controlled trial in Nutrients found that a low-glycemic-index diet reduced fasting insulin by 20 percent over 12 weeks in women with PCOS compared to a standard diet (Barrea et al., 2020).

Practically, this means prioritizing protein and fiber at each meal, reducing refined carbohydrates, and spacing meals to avoid prolonged fasting or large single-carbohydrate loads.

Exercise

Resistance training and aerobic exercise both improve insulin sensitivity. The current PCOS International Evidence-Based Guideline recommends at least 150 minutes of moderate-intensity physical activity per week for adults with PCOS (Teede et al., Human Reproduction, 2018). Providers will tailor this recommendation based on your current activity level and any musculoskeletal limitations.

Sleep and Stress

Sleep disruption worsens insulin resistance independently of diet and exercise. A study in JCEM found that even partial sleep restriction (five hours per night for one week) reduced insulin sensitivity by 20 to 25 percent in healthy adults (Broussard et al., 2012). Providers will ask about sleep quality as part of the intake review, and sleep hygiene recommendations are a routine part of the care plan for patients who report poor sleep.

Cost, Insurance, and Access

Allara accepts many commercial insurance plans. Out-of-pocket costs vary significantly by plan. For patients using insurance, the initial visit is typically billed as an endocrinology or OB/GYN telehealth consultation. The copay structure depends on your specific plan benefits.

Self-pay pricing is publicly listed on Allara's website and has historically ranged from approximately $25 to $75 per visit after the initial membership or intake fee. Lab costs are separate and depend on which lab Allara uses in your area and your insurance coverage for diagnostic bloodwork.

The No Surprises Act, which took effect January 1, 2022, requires providers to give a good-faith cost estimate before scheduled services for uninsured or self-pay patients (CMS, No Surprises Act). Allara is subject to this requirement.

What Makes the Allara Model Different From a Standard OB/GYN Visit

A standard OB/GYN appointment for PCOS typically runs 15 to 20 minutes and may not include a full metabolic panel or a structured nutrition and lifestyle plan. Allara's model allocates more time per visit specifically for hormonal concerns, uses a team that includes registered dietitians alongside physicians and nurse practitioners, and follows up on labs systematically rather than waiting for the patient to call.

The 2018 International Evidence-Based Guideline for PCOS assessment and management, endorsed by 37 organizations worldwide, explicitly recommends a multidisciplinary care model including access to dietetic support, behavioral strategies, and medical management (Teede et al., 2018). Allara's structure aligns with that recommendation more closely than a typical single-provider OB/GYN practice.